Comfort Systems USA Inc vs Zimmer Biomet Holdings Inc — how do they compare? Comfort Systems USA Inc trades at $1,710.56 (market cap $60.06B), while Zimmer Biomet Holdings Inc trades at $89.91 (market cap $16.95B). The key difference: Comfort Systems USA Inc is far larger — about 3.5× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.08%). Which is the better fit depends on your goals — on Pluang, investors hold Comfort Systems USA Inc for 41 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| FIX | ZBH | |
|---|---|---|
Market Cap | $60.06B | $16.95B |
Volume | 371,896 | 2,505,240 |
Sector | Industrials | Health |
52-Week High | $2.07K | $103.98 |
52-Week Low | $790.72 | $79.58 |
Typical Hold Time | 41 Days | 89 Days |
Enterprise Value | $58.53B | $24.02B |
Dividend Yield | 0.21% | 1.08% |
Signals from Pluang's Aura AI — not financial advice
Comfort Systems USA (FIX) trades at $1,715.69, down 1.47% over 24 hours. The stock exhibits a bullish technical signal with strong moving averages, while oscillators are neutral. Fundamentally, the company shows robust growth with revenue rising to $11.2B in 2026 and net income reaching $1.4B, supported by consistent earnings beats. Recent news highlights its strategic positioning in data center and infrastructure projects, including the acquisition of Hunt Electric.
The outlook remains positive given strong analyst consensus (55.56% buy ratings) and a price target of $2,080. Key risks include execution challenges in project estimates and macroeconomic sensitivity. The stock presents a growth opportunity driven by AI infrastructure demand, but investors should monitor backlog conversion and competitive pressures.
Zimmer Biomet (ZBH) trades at $89.14, up 0.73% today, with a bearish technical signal but strong recent earnings beats. The stock shows robust fundamentals with a 69.87% gross margin and 2025 revenue of $8.23B, though net income margin has declined from 2023 peaks. Analyst consensus is a Buy with a $103.11 target, indicating potential upside, supported by a steady dividend and institutional accumulation.
The outlook is mixed: valuation metrics like a P/E of 21.57 appear reasonable, and earnings momentum is positive, but technical weakness and rising debt-to-asset ratios pose risks. Investment appeal hinges on execution of commercial transformations and procedure volume recovery, balancing growth prospects against competitive and operational headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →